Sign up Australia
Proactive Investors - Run By Investors For Investors

IPO Wealth updates stakeholders on fund, and educates on M12 Maximiser products

IPO Wealth (PRIVATE:IPO) managing director James Mawhinney gives Proactive Investors the latest updates on its Australian flagship IPO Wealth fund, and educates the market about the 'M12 maximiser' investment product category.

"We tended to find that a lot of the [High Net Worth] investors were getting fed up with the returns that they were getting on cash investment products such as term deposits, bonds and other similar income-generating type products. And so we saw an opportunity to establish a fund called IPO Wealth that provides a rate of return that's higher, and from our perspective it gives investors the opportunity to often get ahead of inflation... we're very personalised with the approach that we've taken with our clients, and we've got a lot of very happy investors to date," says Mawhinney.

Mawhinney continues, "our investment strategy has been to really work primarily with growth companies. Our portfolio now extends to nine different countries, most of our interests are actually overseas; we're certainly not geographically just focused in one target area, so we are very well-diversified from that perspective. And a lot of our investment strategy more recently has actually been in the provision of credit to businesses that are in the business of providing credit... we've proven the model here works in Australia, and it's a brilliant platform for us to now go and do this in the overseas markets too."

He concludes, "because we're in the business of providing loans or credit out to some of our existing portfolio, the demand is literally in the hundreds and hundreds of millions. So we are very much focused on a) continuing to raise capital, b) continuing to ensure our investor returns are met. I'm pleased to say that since inception of IPO Wealth, we've had a 94.6% retention rate, we've never had to dip into our cash reserve, all redemptions have always been met on time, and our distributions have always been paid on time. We're now providing monthly  distributions as well, which has been a big win for a lot of our investors."

 
Meet Arix Bioscience Plc, Avacta Group Plc and Silence Therapeutics plc at our event, London , 04 October 2018. Register here »
View full IPO profile View Profile

IPO Wealth Timeline

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use